Sales rise 17.90% to Rs 949.42 crore
Net profit of Glaxosmithkline Pharmaceuticals rose 402.80% to Rs 229.88 crore in the quarter ended December 2024 as against Rs 45.72 crore during the previous quarter ended December 2023. Sales rose 17.90% to Rs 949.42 crore in the quarter ended December 2024 as against Rs 805.26 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales949.42805.26 18 OPM %30.7527.08 -PBDT326.90245.85 33 PBT308.10228.74 35 NP229.8845.72 403Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
